| 1 | Clinical use of anti-TNF therapy and increased risk of infec… (10.2147/dhps.s28801) | Abstract References ORCID | 172.74 | 200 |
| 2 | Antidepressant-associated sexual dysfunction: impact, effect… (10.2147/dhps.s7634) | Abstract References ORCID | 169.51 | 181 |
| 3 | Gastrointestinal injury associated with NSAID use: a case st… (10.2147/dhps.s71976) | Abstract References ORCID | 158.29 | 128 |
| 4 | Polycystic ovary syndrome and its impact on women’… (10.2147/dhps.s4388) | Abstract References ORCID License | 146.24 | 28 |
| 5 | Predictors of poor glycemic control in type 2 diabetic patie… (10.2147/dhps.s68786) | Abstract References ORCID | 143.93 | 82 |
| 6 | Point prevalence of hospital-acquired infections in two teac… (10.2147/dhps.s107344) | Abstract References ORCID | 142.73 | 79 |
| 7 | Update on the renal toxicity of iodinated contrast drugs use… (10.2147/dhps.s122207) | Abstract References ORCID | 137.44 | 67 |
| 8 | Use of Streptococcus salivarius K12 in the prevention of str… (10.2147/dhps.s59665) | Abstract References ORCID | 136.96 | 66 |
| 9 | An exploratory study on medications in Qatar homes (10.2147/dhps.s25372) | Abstract References ORCID | 136.47 | 65 |
| 10 | Adverse drug reactions in older patients: an Italian observa… (10.2147/dhps.s29287) | Abstract References ORCID | 130.53 | 54 |
| 11 | Extent of dispensing prescription-only medications without a… (10.2147/dhps.s106948) | Abstract References ORCID | 128.70 | 51 |
| 12 | Prevention of NSAID-related upper gastrointestinal toxicity:… (10.2147/dhps.s4334) | Abstract References ORCID | 127.42 | 49 |
| 13 | Adverse effects of isoniazid preventative therapy for latent… (10.2147/dhps.s68837) | Abstract References ORCID | 126.76 | 48 |
| 14 | Safety and tolerability of zoledronic acid and other bisphos… (10.2147/dhps.s6285) | Abstract References ORCID | 126.09 | 47 |
| 15 | <p>Rational Drug-Use Evaluation Based on World Health… (10.2147/dhps.s237021) | Abstract References ORCID | 121.74 | 41 |
| 16 | Clinical use of antidepressant therapy and associated cardio… (10.2147/dhps.s28804) | Abstract References ORCID | 121.74 | 41 |
| 17 | Prevalence and factors associated with off-label antidepress… (10.2147/dhps.s21079) | Abstract References ORCID | 119.33 | 38 |
| 18 | Information technology in pharmacovigilance: Benefits, chall… (10.2147/dhps.s7180) | Abstract References ORCID | 117.62 | 36 |
| 19 | Safety and tolerability of denosumab for the treatment of po… (10.2147/dhps.s7727) | Abstract References ORCID | 117.62 | 36 |
| 20 | Suicidal behavior and antiepileptic drugs in epilepsy: analy… (10.2147/dhps.s13070) | Abstract References ORCID | 116.72 | 35 |
| 21 | Limitations of widely used high-risk human papillomavirus la… (10.2147/dhps.s37273) | Abstract References ORCID | 116.72 | 35 |
| 22 | Benefit&ndash;risk assessment of new and emerging treatm… (10.2147/dhps.s43304) | Abstract References ORCID | 115.81 | 34 |
| 23 | New developments in the treatment of metastatic melanoma &am… (10.2147/dhps.s39568) | Abstract References ORCID | 114.86 | 33 |
| 24 | Frequency of medication errors in an emergency department of… (10.2147/dhps.s75223) | Abstract References ORCID | 114.86 | 33 |
| 25 | Positive clinical outcomes derived from using <em>Str… (10.2147/dhps.s117214) | Abstract References ORCID | 112.89 | 31 |
| 26 | Application of basic pharmacology and dispensing practice of… (10.2147/dhps.s36409) | Abstract References ORCID | 111.85 | 30 |
| 27 | Awareness among nurses about reporting of adverse drug react… (10.2147/dhps.s31103) | Abstract References ORCID | 110.78 | 29 |
| 28 | Clinical potential, safety, and tolerability of arbaclofen i… (10.2147/dhps.s39595) | Abstract References ORCID | 110.78 | 29 |
| 29 | Topical steroid addiction in atopic dermatitis (10.2147/dhps.s69201) | Abstract References ORCID | 110.78 | 29 |
| 30 | Patient considerations in the use of tapentadol for moderate… (10.2147/dhps.s28829) | Abstract References ORCID | 109.68 | 28 |
| 31 | Evaluation of medication package inserts in Saudi Arabia (10.2147/dhps.s29402) | Abstract References ORCID | 109.68 | 28 |
| 32 | Antiepileptic drugs and suicidality (10.2147/dhps.s13225) | Abstract References ORCID | 108.54 | 27 |
| 33 | Safety and tolerability of antipsychotics: focus on amisulpr… (10.2147/dhps.s6226) | Abstract References ORCID | 108.54 | 27 |
| 34 | Hyperacute drug-induced hepatitis with intravenous amiodaron… (10.2147/dhps.s48640) | Abstract References ORCID | 106.12 | 25 |
| 35 | The economic burden of patient safety targets in acute care:… (10.2147/dhps.s33288) | Abstract References ORCID | 104.85 | 24 |
| 36 | Improving medication management after a hospitalization with… (10.2147/dhps.s56574) | Abstract References ORCID | 104.85 | 24 |
| 37 | Anti-metallothionein IgG and levels of metallothionein in au… (10.2147/dhps.s4342) | Abstract References ORCID License | 104.14 | 10 |
| 38 | Potential drug&ndash;drug interactions in inpatients tre… (10.2147/dhps.s126336) | Abstract References ORCID | 103.52 | 23 |
| 39 | <p>Opioids and frequency counts in the US Food and Dru… (10.2147/dhps.s214771) | Abstract References ORCID | 103.52 | 23 |
| 40 | <p>Evaluation to improve the quality of medication pre… (10.2147/dhps.s184479) | Abstract References ORCID | 100.68 | 21 |
| 41 | Efficacy and safety of gonadotropin-releasing hormone agonis… (10.2147/dhps.s24106) | Abstract References ORCID | 100.68 | 21 |
| 42 | Safety and tolerability of inhalational anticholinergics in… (10.2147/dhps.s7771) | Abstract References ORCID | 100.68 | 21 |
| 43 | Clinical utility, safety, and efficacy of pregabalin in the… (10.2147/dhps.s95535) | Abstract References ORCID | 100.68 | 21 |
| 44 | Clinical safety and tolerability issues in use of triazole d… (10.2147/dhps.s6321) | Abstract References ORCID | 99.17 | 20 |
| 45 | Clinical efficacy, safety, and tolerability of fingolimod fo… (10.2147/dhps.s69640) | Abstract References ORCID | 99.17 | 20 |
| 46 | Prevalence and predictors of antibiotic prescription errors… (10.2147/dhps.s83770) | Abstract References ORCID | 99.17 | 20 |
| 47 | Update on the safety and bioequivalence of biosimilars &… (10.2147/dhps.s28813) | Abstract References ORCID | 97.58 | 19 |
| 48 | Treatment of bipolar disorders during pregnancy: maternal an… (10.2147/dhps.s50556) | Abstract References ORCID | 97.58 | 19 |
| 49 | Early rehospitalizations of frail elderly patients &ndas… (10.2147/dhps.s139237) | Abstract References ORCID | 95.91 | 18 |
| 50 | Insomnia medication use and the probability of an accidental… (10.2147/dhps.s14955) | Abstract References ORCID | 95.91 | 18 |